Lupin Pharmaceuticals received tentative FDA approval for armodafinil tablets in five strengths and doxycycline capsules in one strength. The drugs are generic versions of Cephalon's sleep disorder drug Nuvigil and Galderma Labs' rosacea drug Oracea, respectively. The generic drugs cannot be marketed until patent or market exclusivity protections on the branded versions expire.

Full Story:
Drug Store News

Related Summaries